179 related articles for article (PubMed ID: 29238362)
1. Combined thrombectomy and intracoronary administration of glycoprotein IIb/IIIa inhibitors improves myocardial reperfusion in patients undergoing primary percutaneous coronary intervention: a meta-analysis.
Niu XW; Zhang JJ; Bai M; Peng Y; Zhang Z
J Geriatr Cardiol; 2017 Oct; 14(10):614-623. PubMed ID: 29238362
[TBL] [Abstract][Full Text] [Related]
2. Intracoronary pharmacological therapy versus aspiration thrombectomy in STEMI (IPAT-STEMI): A systematic review and meta-analysis of randomized trials.
Kaddoura R; Mohamed Ibrahim MI; Al-Badriyeh D; Omar A; Al-Kindi F; Arabi AR
PLoS One; 2022; 17(5):e0263270. PubMed ID: 35512007
[TBL] [Abstract][Full Text] [Related]
3. Meta-Analysis of Randomized Trials of Intracoronary Versus Intravenous Glycoprotein IIb/IIIa Inhibitors in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Elbadawi A; Elgendy IY; Megaly M; Ha LD; Mahmoud K; Alotaki E; Ogunbayo GO; Baig B; Abuzaid AS; Saad M; Depta JP
Am J Cardiol; 2017 Oct; 120(7):1055-1061. PubMed ID: 28826897
[TBL] [Abstract][Full Text] [Related]
4. Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis.
Hahn J; Jeon J; Geum MJ; Lee HW; Shin J; Chung WY; Yu YM; Ah YM
Thromb J; 2023 Jul; 21(1):76. PubMed ID: 37452333
[TBL] [Abstract][Full Text] [Related]
5. Intracoronary Thrombolysis in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: an Updated Meta-analysis of Randomized Controlled Trials.
Alexiou S; Patoulias D; Theodoropoulos KC; Didagelos M; Nasoufidou A; Samaras A; Ziakas A; Fragakis N; Dardiotis E; Kassimis G
Cardiovasc Drugs Ther; 2024 Apr; 38(2):335-346. PubMed ID: 36346537
[TBL] [Abstract][Full Text] [Related]
6. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
[TBL] [Abstract][Full Text] [Related]
7. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
Niu X; Zhang J; Bai M; Peng Y; Sun S; Zhang Z
BMC Cardiovasc Disord; 2018 Jan; 18(1):3. PubMed ID: 29320987
[TBL] [Abstract][Full Text] [Related]
8. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
[TBL] [Abstract][Full Text] [Related]
9. Aspiration thrombectomy and intracoronary tirofiban in ST-segment elevation myocardial infarction : Combination treatment for patients undergoing primary percutaneous coronary intervention.
Geng T; Zhang JG; Song ZY; Dai SP; Luo Y; Xu ZS
Herz; 2016 Dec; 41(8):732-740. PubMed ID: 27220978
[TBL] [Abstract][Full Text] [Related]
10. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
[No Abstract] [Full Text] [Related]
11. A comparison of intracoronary with intravenous glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention in patients with acute coronary syndrome: a meta-analysis of randomized controlled trials.
Fu G; Jia L; Zhao X; Wang Y; Chen X; Yang Y; Lu N; Zhao W; Hui R; Zheng Y
J Interv Cardiol; 2012 Jun; 25(3):223-34. PubMed ID: 22413751
[TBL] [Abstract][Full Text] [Related]
12. Intralesional versus intracoronary administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention in patients with acute coronary syndromes: A meta-analysis of randomized controlled trials.
Sun B; Liu Z; Yin H; Wang T; Chen T; Yang S; Jiang Z
Medicine (Baltimore); 2017 Oct; 96(40):e8223. PubMed ID: 28984776
[TBL] [Abstract][Full Text] [Related]
13. Appropriate bolus administration of glycoprotein IIb/IIIa inhibitors for patients with acute coronary syndromes undergoing percutaneous coronary intervention: intracoronary or intravenous? A comprehensive and updated meta-analysis and systematic review.
Ali-Hasan-Al-Saegh S; Mirhosseini SJ; Shahidzadeh A; Rahimizadeh E; Sarrafan-Chaharsoughi Z; Ghodratipour Z; Lotfaliani M; Rezaeisadrabadi M; Dehghan HR; Bireta C; Weymann A; Sabashnikov A; Popov AF
Kardiol Pol; 2016; 74(2):104-18. PubMed ID: 26202532
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of randomized controlled trials comparing intracoronary and intravenous administration of glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction.
Wang Y; Wu B; Shu X
Am J Cardiol; 2012 Apr; 109(8):1124-30. PubMed ID: 22245413
[TBL] [Abstract][Full Text] [Related]
15. Intracoronary Glycoprotein IIb/IIIa Inhibitors Improve Short-Term Mortality and Reinfarction in East Asian Patients with ST-Segment Elevation Myocardial Infarction after Thrombus Aspiration: A Meta-Analysis.
Wu JH; Hao PP; Chen YG; Li RJ
Evid Based Complement Alternat Med; 2018; 2018():5174714. PubMed ID: 30186355
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of intracoronary versus intravenous tirofiban in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
Tian R; Liu R; Zhang J; Li Y; Wei S; Xu F; Li X; Li C
Heliyon; 2023 May; 9(5):e15842. PubMed ID: 37180928
[TBL] [Abstract][Full Text] [Related]
17. Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials.
Kumbhani DJ; Bavry AA; Desai MY; Bangalore S; Bhatt DL
J Am Coll Cardiol; 2013 Oct; 62(16):1409-18. PubMed ID: 23665372
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of intracoronary pro-urokinase injection during percutaneous coronary intervention in treating ST elevation myocardial infarction patients: a systematic review and meta-analysis of randomized controlled trials.
Yin XS; Huang YW; Li ZP; Dong JL; Zou JM; Tian L; Yang J
Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5802-5813. PubMed ID: 36066155
[TBL] [Abstract][Full Text] [Related]
19. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
[TBL] [Abstract][Full Text] [Related]
20. Local Intracoronary Infusion of Glycoprotein IIb/IIIa Inhibitors via a Perfusion Catheter versus Intracoronary Guiding Catheter Injection during Primary Percutaneous Coronary Intervention: A Pilot Observational Study.
Zaki T; Labib S; El-Abbady M; El-Kilany W; Mortada A; Rashid T; Ragy H; El-Itreby A; Nammas W
Acta Cardiol Sin; 2017 May; 33(3):258-265. PubMed ID: 28559656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
